Skip to main content
SpringerLink
Log in

Care of the Patient Who Misuses Drugs

  • Chapter
Taylor’s Diagnostic and Therapeutic Challenges

  • 471 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Farre M, De La Torre R, Gonzalez M, Roset PN, Menoyo E, Cami J. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 1997;283:164–76.

    PubMed  CAS  Google Scholar 

  2. Heesch CM, Wilhelm CR, Ristic J, Adnane J, Bontepo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000;83:688–95.

    Article  PubMed  CAS  Google Scholar 

  3. Goldfrank LR, Hoffman RS. The cardiovascular effects of cocaine. Ann Emerg Med 1991;20:165–75.

    Article  PubMed  CAS  Google Scholar 

  4. Nolan AG. Recreational drug misuse: issues for the cardiologist. Heart 2000;83:627–33.

    PubMed  Google Scholar 

  5. Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine. Circulation 1999;99:2737–41.

    PubMed  CAS  Google Scholar 

  6. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med 1994;1:330–9.

    PubMed  CAS  Google Scholar 

  7. McNagny SD, Parker RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. JAMA 1992;267:1106–8.

    Article  PubMed  CAS  Google Scholar 

  8. Trabulsy ME. Cocaine washed out syndrome in a patient with acute myocardial infarction. Am J Emerg Med 1995;13:538–9.

    Article  PubMed  CAS  Google Scholar 

  9. Rubin RB, Neugarten J. Cocaine-induced rhabdomyolysis masquerading as myocardial ischemia. Am J Med 1989;86:551–3.

    Article  PubMed  CAS  Google Scholar 

  10. Brogan WC, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991;18:581–6.

    PubMed  Google Scholar 

  11. Hollander JE, Burstein JL, Hoffman RS, Shih RD, Wilson LD. Cocaineassociated myocardial infarction. Chest 1995;107:1237–41.

    PubMed  CAS  Google Scholar 

  12. Hogya PT, Wolfson AB. Chronic cocaine abuse associated with dilated cardiomyopathy. Am J Emerg Med 1991;8:203–4.

    Google Scholar 

  13. Kerns W, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997;15(3):321–9.

    Article  PubMed  Google Scholar 

  14. Stevens DC, Campbell JP, Carter JE, Waston WA. Acid-base abnormalities associated with cocaine toxicity in emergency department patients. Clin Toxicol 1994;32:31–9.

    CAS  Google Scholar 

  15. Om A, Ellahham S, DiSciascio G. Management of cocaine-induced cardiovascular complications. Am Heart J 1993;125:469–75.

    PubMed  CAS  Google Scholar 

  16. June R, Aks SE, Keys N, Wahl M. Medical outcome of cocaine bodystuffers. J Emerg Med 2000;18(2):221–4.

    Article  PubMed  CAS  Google Scholar 

  17. Mott SH, Packer RJ, Soldin SJ. Neurologic manifestations of cocaine exposure in childhood. Pediatrics 1994;93:557–60.

    PubMed  CAS  Google Scholar 

  18. Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986;108:456–9.

    PubMed  CAS  Google Scholar 

  19. Cohen HR, Green JR, Crombleholm WR. Peripartum cocaine use: estimating risk of adverse pregnancy outcome. Int J Gynecol Obstet 1991; 35:51–4.

    Article  CAS  Google Scholar 

  20. Frassica JJ, Orav EJ, Walsh EP, Lipshultz SE. Arrhythmias in children prenatally exposed to cocaine. Arch Pediatr Adolesc Med 1994;148: 1163–9.

    PubMed  CAS  Google Scholar 

  21. Arendt R, Angelopoulos J, Salvator A, Singer L. Motor development of cocaine-exposed children at age two years. Pediatrics 1999;103:86–92.

    Article  PubMed  CAS  Google Scholar 

  22. Haim DY, Lippmann ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. Chest 1995;107:233–49.

    PubMed  CAS  Google Scholar 

  23. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 1988;319:673–7.

    PubMed  CAS  Google Scholar 

  24. DAWN Report (dy2000). Substance Abuse and Mental Health Services Administration. Available at www.samhsa.gov.

    Google Scholar 

  25. Osterwalder JJ. Naloxone—for intoxication with intravenous heroin and heroin mixtures—harmless of hazardous? J Toxicol Clin Toxicol 1996; 34(4):409–16.

    PubMed  CAS  Google Scholar 

  26. Smith DA, Leake L, Loflin JR, Yealy DM. Is admission after intravenous heroin overdose necessary? Ann Emerg Med 1992;21:1326–30.

    PubMed  CAS  Google Scholar 

  27. Levy M, Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacological management. Pharmacotherapy 1993;13:202–11.

    PubMed  CAS  Google Scholar 

  28. O’Connor PG, Fiellin DA. Pharmacologic treatment of heroindependent patients. Ann Intern Med 2000;133:40–54.

    Google Scholar 

  29. Buxton N, McConachie NS. Amphetamine abuse and intracranial haemorrhage. J R Soc Med 2000;93:472–7.

    PubMed  CAS  Google Scholar 

  30. Mathias R. Student’s use of marijuana, other illicit drugs, and cigarettes continued to rise in 1995. NIDA Notes 1996;Jan/Feb. Vol III(1). Available online http://165.112.61/NIDAHome.html under NIDA Notes Newsletter.

    Google Scholar 

  31. Solwij N. Do cognitive impairments recover following cessation of cannabis use? Life Sci 1995;56:2119–26.

    Google Scholar 

  32. Zhu LX, Sharma S, Stolina M, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine dependent pathway. J Immunol 2000;165(1):373–80.

    PubMed  CAS  Google Scholar 

  33. Zickler P. Annual survey finds increasing teen use of ecstasy, steroids. NIDA Notes 2001;16(2). Available online http://165.112.61/NIDAHome. html under NIDA Notes Newsletter.

    Google Scholar 

  34. Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001;63:1–22.

    PubMed  CAS  Google Scholar 

  35. Waltzman ML. Flunitrazepam: A review of “roofies”. Pediatr Emerg Care 1999;15(1):59–60.

    PubMed  CAS  Google Scholar 

  36. Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001;63:1–22.

    PubMed  CAS  Google Scholar 

  37. Blaho K, Merigian K, Winbery S, Geraci SA, Smartt C. Clinical pharmacology of lysergic acid diethylamine: case reports and review of the treatment of intoxication. Am J Ther 1997;4:211–21.

    PubMed  CAS  Google Scholar 

  38. Kurtzman TL, Otsuka K, Wahl R. Inhalant abuse by adolescents. J Adolesc Health 2001;28:170–80.

    Article  PubMed  CAS  Google Scholar 

  39. Schulz JE. The integration of medical management with recovery. J Psychoactive Drugs 1997;29(3):233–7.

    PubMed  CAS  Google Scholar 

  40. Fleming MF, Barry RL, Manwell LB, Johnson, London R. Brief physicians’ advice for problem alcohol drinkers: a randomized controlled trial in community based primary care practice. JAMA 1997;277:1039–45.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jerome E. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, OR, 97201-3098, USA

    Robert B. Taylor M.D. (Professor Emeritus) (Professor Emeritus)

  2. Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, WI, 53226-0509, USA

    Alan K. David M.D. (Professor and Chairman) (Professor and Chairman)

  3. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, OR, 97201-3098, USA

    Scott A. Fields M.D. (Professor and Vice Chairman) (Professor and Vice Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216-4500, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. Department of Family and Preventive Medicine, University of California, San Diego School of Medicine, San Diego, California, 92103-0801

    Joseph E. Scherger M.D., M.P.H. (Clinical Professor) (Clinical Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Schulz, J.E. (2005). Care of the Patient Who Misuses Drugs. In: Taylor, R.B., David, A.K., Fields, S.A., Phillips, D.M., Scherger, J.E. (eds) Taylor’s Diagnostic and Therapeutic Challenges. Springer, New York, NY. https://doi.org/10.1007/0-387-27287-9_8

Download citation

  • DOI: https://doi.org/10.1007/0-387-27287-9_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22337-7

  • Online ISBN: 978-0-387-27287-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation